Literature DB >> 2997324

Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature.

D Carrasco, M Prieto, L Pallardó, J L Moll, J M Cruz, C Muñoz, J Berenguer.   

Abstract

We report a case of multiple hepatic adenomas developed in a 32-year-old man with renal allograft after long-term therapy with testosterone enanthate. Histological assessment showed a benign hepatocellular adenoma, which has not regressed over a 6-month follow-up since androgen withdrawal. A review of primary hepatic tumors associated with androgenic-anabolic steroid therapy published in the English literature has been carried out, concentrating on the more relevant recent publications. No previous case of hepatic adenoma with possible relationship to the use of non-17-alpha alkylated compounds has been reported.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997324     DOI: 10.1016/s0168-8278(85)80001-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

Review 1.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

Review 2.  Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review.

Authors:  John Nasr; Jawad Ahmad
Journal:  Dig Dis Sci       Date:  2008-08-22       Impact factor: 3.199

Review 3.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

Review 4.  Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature.

Authors:  A Kosaka; H Takahashi; Y Yajima; M Tanaka; K Okamura; R Mizumoto; K Katsuta
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 5.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 6.  Adverse effects of anabolic steroids.

Authors:  R C Hickson; K L Ball; M T Falduto
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

7.  Hepatic tumours during androgen therapy in Fanconi anaemia.

Authors:  R L Touraine; Y Bertrand; P Foray; J Gilly; N Philippe
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

8.  Measurement of androgen receptor expression in adult liver, fetal liver, and Hep-G2 cells by the polymerase chain reaction.

Authors:  A P Stubbs; J L Engelman; J I Walker; P Faik; G M Murphy; M L Wilkinson
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

9.  Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Authors:  Sanjay Kakar; Xin Chen; Coral Ho; Lawrence J Burgart; Oyedele Adeyi; Dhanpat Jain; Viabhav Sahai; Linda D Ferrell
Journal:  Histopathology       Date:  2009-08       Impact factor: 5.087

Review 10.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.